campus banner

Charleston HFpEF Conference Agenda

Friday, August 8

2:00 p.m.  -  Registration

2:30 p.m.  -  Welcome

2:40 p.m.  -  What does "Preserved EF" Mean? Re-evaluating the Use of Ejection Fraction in Patients with Heart Failure, Javed Butler, M.D.

3:15 p.m.  -  Subphenotyping of HFpEF, Gregory Lewis, M.D.

3:45 p.m.  -  Matrix & Fibrosis: Pathophysiology, Diagnosis and Treatment Target, Michael Zile, M.D.

4:15 p.m.  -  Nonpharmacological Treatments for HFpEF: InterAtrial Shunt Devices, Pericardiectomy, and Exercise Training, Sheldon Litwin, M.D.

4:45 p.m.  -  Questions

5:00 p.m.  -  Reception and Exhibit Showcase


Saturday, August 9

7:00 a.m.  -  Breakfast and Case Discussions

8:00 a.m.  -  Obesity and Weight Management in HFpEF, Sheldon Litwin, M.D.

8:30 a.m.  -  RV function and RV failure, Ryan Tedford, M.D.

9:00 a.m.  -  Invasive Pressure Measurements, Role of Invasive Exercise Testing in HFpEF, Brian Houston, M.D.

9:30 a.m.  -  Questions

9:40 a.m.  -  Break

10:00 a.m.  -  Drug Therapy for HFpEF - Neurohormonal Modulation; Which Diuretic is Best? Michael Zile, M.D.

10:30 a.m.  -  Pulmonary Embolism as a Contributor to HFpEF: Does Aggressive Early Treatment Mitigate Long-Term Consequences? Thomas Todoran, M.D.

11:00 a.m.  -  Ambulatory Invasive Pressure Monitoring, William Abraham, M.D.

11:30 a.m.  -  Questions

11:45 a.m.  -  Lunch on your own

1:00 p.m.  -  Kidney Disease (Acute and Chronic): Role of Dialysis in Chronic and Acute Decompensated HFpEF, Ruth Campbell, M.D.

1:30 p.m.  -  Atrial fibrillation and HFpEF: Pathophysiology and Target for Treatment of HFpEF, J. Marcus Wharton, M.D.

2:00 p.m.  -  NAFLD and HFpEF, Wing-Kin Syn, M.D.

2:30 p.m.  -  Questions

3:00 p.m.  -  Amyloidosis, a Treatable Form of HFpEF, Daniel Judge, M.D.

3:30 p.m.  -  Diabetes: Pathophysiology and Evolving Pharmacological Therapy, Javed Butler, M.D.

4:00 p.m.  -  Pacing for HFpEF? Treating Chronotropic Incompetence and Mid-Range EF with Wide QRS, Michael Gold, M.D.

4:30 p.m.  -  Questions

Sunday, August 10

7:00 a.m.  -  Breakfast and Cases

8:00 a.m.  -  Stimulating New Treatments for Heart Failure: Baroreceptor Stimulation/Autonomic Modulation; Phrenic Nerve Stimulation; Myocardial Stimulation (Cardiac Contractility Modulation), William Abraham, M.D.

8:30 a.m.  -  Abnormalities of Oxygen Utilization Pathways in HFpEF, Gregory Lewis, M.D.

9:00 a.m.  -  Imaging for Diagnosis and Assessment of HFpEF (Echo, CT, MRI), Sheldon Litwin, M.D.

9:30 a.m.  -  Questions

9:45 a.m.  -  Break

10:00 a.m.  -  Pulmonary Disease as Contributing Factor to HFpEF: OSA, COPD, Rahul Argula, M.D.

10:30 a.m.  -  HCM and Septal Ablation: Part of HFpEF? Christopher Nielson, M.D.

11:00 a.m.  -  Biomarkers in HFpEF, Michael Zile, M.D.

11:30 a.m.  -  Questions

11:45 a.m.  -  Wrap up, Sheldon Litwin, M.D.

12:00 p.m.  -  Adjourn